The technology could help reduce the number of COVID deaths from a pandemic, according to a new report from Caltech’s Artificial Intelligence Laboratory.
The technology, known as “deep learning,” has the potential to make life better for people by improving our understanding of the biological process that causes illness.
Caltech, one of the nation’s leading universities in artificial intelligence and machine learning, has been working to create this type of AI for the past year.
The institute’s research group, which includes experts from a number of countries including China and India, is developing algorithms that would help doctors better understand how the disease progresses and predict how to treat it.
In an effort to make its findings more broadly applicable to the pandemic — and to understand how to improve treatments and healthcare systems — Caltech is developing an AI to aid in the development of vaccines, drug treatments and vaccines.
CalTech researchers have used deep learning to help build a computer program that helps predict the effectiveness of new antibiotics in combating the coronavirus.
CalT’s research team has built the software, called CalT_Data.
It is now being used in clinical trials for diagnostics, which could improve diagnosis and treatment of people who have not received timely vaccines.
The team also developed a tool that allows doctors to analyze data from more than 200,000 cases of COH-1, including cases in which the person had not been vaccinated.
CalT is also developing software that can help identify people who might have been exposed to COHs, and it has been developing a tool to help researchers identify people at risk for future infections.
CalMets team also works with researchers in other countries to train deep learning algorithms for detecting signs of COID-19 in the data.
The researchers say they have developed software that has the capacity to predict the efficacy of more than 400 vaccines, which are used to protect millions of people from COVIDs, by 2020.
They say they hope to train more than 100,000 AI systems that could improve the effectiveness and efficiency of vaccines and other treatments.